CONTEXT AND OBJECTIVE: Coronavirus disease 2019 (COVID-19) has emerged in
China in December 2019 and rapidly spread. Although extraordinary efforts
have been made on research regarding pharmacological interventions, none have
proven effective. This is the protocol for a rapid living
systematic review that aims to compare the effectiveness and safety
of different pharmacological interventions for the treatment of COVID-19.